Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast

Forecasting

Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk

Rating of Russian Pharmaceutical Distributors (Q1 – Q2 2017)

Wednesday, August 23, 2017

The first half of 2017 was very vigorous for Russian pharmaceutical distributors. First, the wholesalers initiated several large, if not to say core, transactions. Representatives of Marathon Pharma announced a global partnership with Nacimbio, which is interesting in the first place for the scale of the public-private partnership. This should be a logical completion of the infrastructure of the pharmaceutical assets of Rostec. However, not every company managed to get larger, in particular, once one of the largest players of the Russian pharmaceutical wholesale Rosta sold its chain Raduga to Doktor Stoletov. While the future of Doktor Stoletov is quite obvious after the end of the integration period, the future of Rosta is rather ambiguous.

Secondly, the distributors continued the development of their own retail through the purchase of existing pharmacy chains. In particular, Grand Capital bought the chain Metr (Bryansk), and Protek bought DOMfarma (Kolomna). Both Metr and DOMfarma are very strong regional chains with a long history.

Finally, in addition to the development of the core competencies of wholesale companies, the tendency of diversifying the investment portfolio of certain Russian pharmaceutical wholesalers into non-pharmaceutical areas was quite evident. In particular, Aleksei Repik (R-Pharm) announced investments in a hotel complex in Yaroslavl, and Viktor Kharitonin (Pharmstandard) bought the shopping center Gorbushkin Dvor.

Read more about rating of Russian pharmaceutical Distributors(Q1 2017 performance) here: http://rncph.com/news/31_05_2017

See the detailed rating in the newspaper Farmatsevtichesky Vestnik (No. 26, 08/29/2017).

Tab 1. Top 15 pharmaceutical distributors with the largest market share of direct shipments of drugs (including preferential shipments), in monetary terms (Q1 – Q2 2017)

Share: